Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Mollaret Cells in Recurrent Benign Lymphocytic Meningitis.

Gluck L, Robbins M, Galen B.

Neurohospitalist. 2019 Jan;9(1):49-50. doi: 10.1177/1941874417754029. Epub 2018 Jan 24. No abstract available.

PMID:
30671166
2.

Recordings in an integrating central neuron provide a quick way for identifying appropriate anaesthetic use in fish.

Machnik P, Schirmer E, Glück L, Schuster S.

Sci Rep. 2018 Dec 3;8(1):17541. doi: 10.1038/s41598-018-36130-8.

3.

The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization.

Adam C, Glück L, Ebert R, Goebeler M, Jakob F, Schmidt M.

Bone. 2018 Jun;111:49-58. doi: 10.1016/j.bone.2018.03.020. Epub 2018 Mar 19.

PMID:
29567200
4.

Convergence Spasm in Wernicke Encephalopathy.

Shabbir S, Tong O, Gluck L, Robbins M.

Neurohospitalist. 2018 Jan;8(1):NP1-NP2. doi: 10.1177/1941874417690668. Epub 2017 Jan 29. Review. No abstract available.

5.

First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors.

Papadopoulos KP, Gluck L, Martin LP, Olszanski AJ, Tolcher AW, Ngarmchamnanrith G, Rasmussen E, Amore BM, Nagorsen D, Hill JS, Stephenson J Jr.

Clin Cancer Res. 2017 Oct 1;23(19):5703-5710. doi: 10.1158/1078-0432.CCR-16-3261. Epub 2017 Jun 27.

6.

And Walls Shall Break: The ISBER 2016 Annual Meeting and Exhibits.

Lermen D, Glück L, Schirmacher P.

Biopreserv Biobank. 2016 Jun;14(3):260-1. doi: 10.1089/bio.2016.29006.djl. No abstract available.

PMID:
27249327
7.

2016 ISBER Annual Meeting and Exhibits in Berlin-"Breaking Down Walls: Unifying Biobanking Communities to Secure Our Sustainability".

Lermen D, Glück L, Schirmacher P.

Biopreserv Biobank. 2016 Feb;14(1):84-6. doi: 10.1089/bio.2016.28999.djI. Epub 2016 Jan 28. No abstract available.

PMID:
26866585
8.

Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.

Ádori C, Glück L, Barde S, Yoshitake T, Kovacs GG, Mulder J, Maglóczky Z, Havas L, Bölcskei K, Mitsios N, Uhlén M, Szolcsányi J, Kehr J, Rönnbäck A, Schwartz T, Rehfeld JF, Harkany T, Palkovits M, Schulz S, Hökfelt T.

Acta Neuropathol. 2015 Apr;129(4):541-63. doi: 10.1007/s00401-015-1394-3. Epub 2015 Feb 13.

PMID:
25676386
9.

Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.

Glück L, Loktev A, Moulédous L, Mollereau C, Law PY, Schulz S.

Biol Psychiatry. 2014 Nov 15;76(10):767-74. doi: 10.1016/j.biopsych.2014.01.021. Epub 2014 Feb 3.

10.

Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain.

Shi TJ, Xiang Q, Zhang MD, Barde S, Kai-Larsen Y, Fried K, Josephson A, Glück L, Deyev SM, Zvyagin AV, Schulz S, Hökfelt T.

Mol Pain. 2014 Feb 13;10:12. doi: 10.1186/1744-8069-10-12.

11.

Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: results of a Phase II trial.

Reynolds C, Spira AI, Gluck L, Bradie-Muller SJ, Zhan F, Boehm KA, Asmar L.

Invest New Drugs. 2013 Oct;31(5):1330-8. doi: 10.1007/s10637-013-9985-0. Epub 2013 Jun 13. Erratum in: Invest New Drugs. 2013 Dec;31(6):1628. Mueller, Suzanne E [corrected to Bradie-Muller, Suzanne J].

PMID:
23761052
12.

Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.

Doll C, Pöll F, Peuker K, Loktev A, Glück L, Schulz S.

Br J Pharmacol. 2012 Nov;167(6):1259-70. doi: 10.1111/j.1476-5381.2012.02080.x.

13.

Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.

Grecksch G, Just S, Pierstorff C, Imhof AK, Glück L, Doll C, Lupp A, Becker A, Koch T, Stumm R, Höllt V, Schulz S.

J Neurosci. 2011 Sep 28;31(39):13890-6. doi: 10.1523/JNEUROSCI.2304-11.2011.

14.

Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice.

Imhof AK, Glück L, Gajda M, Bräuer R, Schaible HG, Schulz S.

Arthritis Res Ther. 2011 Jun 20;13(3):R97. doi: 10.1186/ar3372.

15.

Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis.

Imhof AK, Glück L, Gajda M, Lupp A, Bräuer R, Schaible HG, Schulz S.

Arthritis Rheum. 2011 Aug;63(8):2352-62. doi: 10.1002/art.30410.

16.

Evaluation of a new commercial TaqMan PCR assay for direct detection of the clostridium difficile toxin B gene in clinical stool specimens.

Stamper PD, Babiker W, Alcabasa R, Aird D, Wehrlin J, Ikpeama I, Gluck L, Carroll KC.

J Clin Microbiol. 2009 Dec;47(12):3846-50. doi: 10.1128/JCM.01490-09. Epub 2009 Oct 21.

17.

Quality control of plasmid preparations.

Gluck L, Alazay L, Ratel D, Puget S, Wion D.

Nat Biotechnol. 2001 Aug;19(8):715. No abstract available.

PMID:
11479556
18.

Evidence for short-patch mismatch repair in Saccharomyces cerevisiae.

Coïc E, Gluck L, Fabre F.

EMBO J. 2000 Jul 3;19(13):3408-17.

19.

Editorial: The jargonic disaster: or whom* wrote that note? 1985.

Gluck L, Martin GI, Pomerance JJ.

J Perinatol. 1998 Sep-Oct;18(5):337. No abstract available.

PMID:
9766406
20.

A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.

Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ.

J Pharmacol Exp Ther. 1998 Oct;287(1):187-97.

PMID:
9765337
21.

Diagnosis of the respiratory distress syndrome by amniocentesis. 1971.

Gluck L, Kulovich MV, Borer RC Jr, Brenner PH, Anderson GG, Spellacy WN.

Am J Obstet Gynecol. 1995 Aug;173(2):629; discussion 630. No abstract available.

PMID:
7645644
22.

Diphenhydramine-induced delirium in elderly hospitalized patients with mild dementia.

Tejera CA, Saravay SM, Goldman E, Gluck L.

Psychosomatics. 1994 Jul-Aug;35(4):399-402. No abstract available.

PMID:
8084991
23.

Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.

Merz CS, Kramer C, Forman M, Gluck L, Mills K, Senft K, Steiman I, Wallace N, Charache P.

J Clin Microbiol. 1994 May;32(5):1142-7.

24.

Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A.

Nanus DM, Engelstein D, Gastl GA, Gluck L, Vidal MJ, Morrison M, Finstad CL, Bander NH, Albino AP.

Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7069-73.

25.

Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up.

Minasian LM, Motzer RJ, Gluck L, Mazumdar M, Vlamis V, Krown SE.

J Clin Oncol. 1993 Jul;11(7):1368-75.

PMID:
8315435
26.

Reintroduction of continuous negative pressure ventilation in neonates: two-year experience.

Cvetnic WG, Cunningham MD, Sills JH, Gluck L.

Pediatr Pulmonol. 1990;8(4):245-53.

PMID:
2196512
27.

Regulation of immune functions by human surfactant.

Shimizu M, Vayuvegula B, Ellis M, Gluck L, Gupta S.

Ann Allergy. 1988 Dec;61(6):459-62.

PMID:
2974258
28.

Hypoxanthine: a marker for asphyxia.

Pietz J, Guttenberg N, Gluck L.

Obstet Gynecol. 1988 Nov;72(5):762-6.

PMID:
3140152
29.

Radiotoxicities of [3H]thymidine and of [3H]arginine compared in mouse embryos in vitro.

Müller WU, Streffer C, Molls M, Glück L.

Radiat Res. 1987 May;110(2):192-8.

PMID:
3575650
31.

Correlation of plasma hypoxanthine and catecholamine levels in the umbilical vein.

Saugstad OD, Ziegler MG, Kessel B, Saunders B, Gluck L.

J Perinat Med. 1986;14(5):339-43.

PMID:
3783399
32.

Lung profile: sex differences in normal pregnancy.

Fleisher B, Kulovich MV, Hallman M, Gluck L.

Obstet Gynecol. 1985 Sep;66(3):327-30.

PMID:
4022494
33.

Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial.

Hallman M, Merritt TA, Jarvenpaa AL, Boynton B, Mannino F, Gluck L, Moore T, Edwards D.

J Pediatr. 1985 Jun;106(6):963-9.

PMID:
3889259
34.

Real time ultrasound diagnosis of hemorrhagic pathological conditions in the posterior fossa of preterm infants.

Bejar R, Coen RW, Ekpoudia I, James HE, Gluck L.

Neurosurgery. 1985 Mar;16(3):281-9.

PMID:
3982605
35.

Role of myoinositol in regulation of surfactant phospholipids in the newborn.

Hallman M, Saugstad OD, Porreco RP, Epstein BL, Gluck L.

Early Hum Dev. 1985 Jan;10(3-4):245-54.

PMID:
3838720
36.

Ventriculoperitoneal shunts in high risk newborns weighing under 2000 grams: a clinical report.

James HE, Bejar R, Gluck L, Coen R, Merritt A, Mannino F, Bromberger P, Saunders B, Schneider H.

Neurosurgery. 1984 Aug;15(2):198-202.

PMID:
6483138
37.

Hypoxanthine and oxygen induced lung injury: a possible basic mechanism of tissue damage?

Saugstad OD, Hallman M, Abraham JL, Epstein B, Cochrane C, Gluck L.

Pediatr Res. 1984 Jun;18(6):501-4.

PMID:
6610852
38.

Minimizing bronchopulmonary dysplasia in VLBW infants.

Boynton BR, Mannino FL, Randel RC, Merritt TA, Coen RW, Edwards D, Gluck L.

J Pediatr. 1984 Jun;104(6):962-3. No abstract available.

PMID:
6547172
39.

Management of hydrocephalus secondary to intracranial hemorrhage in the high risk newborn.

James HE, Bejar R, Merritt A, Gluck L, Coen R, Mannino F.

Neurosurgery. 1984 May;14(5):612-8.

PMID:
6728175
40.
41.

Increased hypoxanthine concentrations in cerebrospinal fluid of infants with hydrocephalus.

Bejar R, Saugstad OD, James H, Gluck L.

J Pediatr. 1983 Jul;103(1):44-8.

PMID:
6864395
42.

Reduction of lung injury by human surfactant treatment in respiratory distress syndrome.

Merritt TA, Cochrane CG, Hallman M, Holcomb KE, Strayer D, Mannino F, Edwards DK 3rd, Gluck L.

Chest. 1983 May;83(5 Suppl):27S-31S. No abstract available.

PMID:
6601570
43.

Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome.

Hallman M, Merritt TA, Schneider H, Epstein BL, Mannino F, Edwards DK, Gluck L.

Pediatrics. 1983 Apr;71(4):473-82. No abstract available.

PMID:
6340042
44.

Doppler debate continued.

Bejar R, Merritt TA, Coen RW, Mannino F, Gluck L.

Pediatrics. 1983 Mar;71(3):471-2. No abstract available.

PMID:
6828365
45.

Respiratory distress syndrome--update 1982.

Hallman M, Gluck L.

Pediatr Clin North Am. 1982 Oct;29(5):1057-75. Review. No abstract available.

PMID:
6752851
47.

Preschool assessment of infants with a patent ductus arteriosus: comparison of ligation and indomethacin therapy.

Merritt TA, White CL, Coen RW, Friedman WF, Gluck L, Rosenberg M.

Am J Dis Child. 1982 Jun;136(6):507-12.

PMID:
7091062
48.

Pulsatility index, patent ductus arteriosus, and brain damage.

Bejar R, Merritt TA, Coen RW, Mannino F, Gluck L.

Pediatrics. 1982 Jun;69(6):818-22. No abstract available.

PMID:
7079053
49.

Determination of plasma hypoxanthine: a comparison of high-pressure liquid chromatographic and oxygen consumption methods.

Saugstad OD, Wung WE, Howell SB, Gluck L.

Anal Biochem. 1982 May 1;122(1):159-63. No abstract available.

PMID:
7103081
50.

Supplemental Content

Support Center